L057-0253 Screening compound: N-{[1-(4-METHYLBENZOYL)-2,3-DIHYDRO-1H-INDOL-6-YL]METHYL}-N'-TETRAHYDRO-2-FURANYLMETHYLUREA

L057-0253 Screening compound: N-{[1-(4-METHYLBENZOYL)-2,3-DIHYDRO-1H-INDOL-6-YL]METHYL}-N'-TETRAHYDRO-2-FURANYLMETHYLUREA
L057-0253 Screening compound: N-{[1-(4-METHYLBENZOYL)-2,3-DIHYDRO-1H-INDOL-6-YL]METHYL}-N'-TETRAHYDRO-2-FURANYLMETHYLUREA alternative view

Chemical Structure Depiction of ChemDiv screening compound L057-0253
N-{[1-(4-METHYLBENZOYL)-2,3-DIHYDRO-1H-INDOL-6-YL]METHYL}-N'-TETRAHYDRO-2-FURANYLMETHYLUREA

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L057-0253

Molecular Formula

C23H27N3O3 (C23 H27 N3 O3)

Compound Name

N-{[1-(4-METHYLBENZOYL)-2,3-DIHYDRO-1H-INDOL-6-YL]METHYL}-N'-TETRAHYDRO-2-FURANYLMETHYLUREA

IUPAC name

n/a

SMILES

Cc(cc1)ccc1C(N(CC1)c2c1ccc(CNC(NCC1OCCC1)=O)c2)=O

InChI

InChI=1S/C23H27N3O3/c1-16-4-7-19(8-5-16)22(27)26-11-10-18-9-6-17(13-21(18)26)14-24-23(28)25-15-20-3-2-12-29-20/h4-9,13,20H,2-3,10-12,14-15H2,1H3,(H2,24,25,28)/t20-/m1/s1

InChI Key

SWYLAPQOLOAAHO-HXUWFJFHSA-N

MDL Number (MFCD)

MFCD27227044

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

393.49

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.406

Distribution Coefficient, logD

2.406

Water Solubility, LogSw

-2.79

Polar Surface Area

59.519

Acid Dissociation Constant (pKa)

14.13

Base Dissociation Constant (pKb)

4.83

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.10

L057-0253 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Nucleic Acid Ligands (8311 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L057-0253 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L057-0253?
Check Price and Availability of L057-0253, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L057-0253 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L057-0253
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L057-0253
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L057-0253 available by request